These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3513030)

  • 61. [Controversial questions of current chemotherapy of tuberculosis].
    Eínis VL; Tuganova VE
    Probl Tuberk; 1966; 44(3):20-6. PubMed ID: 5995847
    [No Abstract]   [Full Text] [Related]  

  • 62. [Infectiology of the urogenital tract. 7: Therapy of urogenital tuberculosis--side-effects--drugs--interactions--dose adjustment in decreased kidney function].
    Brühl P
    Fortschr Med; 1997 Jun; 115(18):44-6. PubMed ID: 9324487
    [No Abstract]   [Full Text] [Related]  

  • 63. [Recommendations of the Problemkommission Lungenkrankheiten und Tuberkulose for drug therapy of tuberculosis].
    Steinbeck P; Landmann H
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):149-59. PubMed ID: 5303391
    [No Abstract]   [Full Text] [Related]  

  • 64. Capreomycin and other drugs in the treatment of pulmonary tuberculosis.
    Zierski M
    Tubercle; 1969 Mar; 50():Suppl:37-9. PubMed ID: 4319132
    [No Abstract]   [Full Text] [Related]  

  • 65. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

  • 66. Results and therapeutic consequences of general resistance tests in tuberculosis of the urogenital system (author's transl).
    Gabler A
    Med Klin; 1973 Dec; 68(50):4648-52. PubMed ID: 4131488
    [No Abstract]   [Full Text] [Related]  

  • 67. [Chemotherapy of pulmonary tuberculosis].
    Zbikowski H
    Pneumonol Pol; 1980 Jun; 48(6):393-8. PubMed ID: 6773038
    [No Abstract]   [Full Text] [Related]  

  • 68. [Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].
    Blanco Ramos JR; Rosel Rioja L; Dopereiro Gómez R; Oteo Revuelta JA
    An Med Interna; 1997 Aug; 14(8):433-4. PubMed ID: 9376493
    [No Abstract]   [Full Text] [Related]  

  • 69. [Chemo-antibiotic resis tance and clinicoradiologic patterns of the disease in patients with chronic pulmonary tuberculosis].
    Giura R
    G Ital Mal Torace; 1967; 21(4):205-9. PubMed ID: 4970415
    [No Abstract]   [Full Text] [Related]  

  • 70. [Primary mycobacterial resistance and its relations to the clinical aspects and therapy of tuberculosis].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1967 Jun; 22(6):519-34. PubMed ID: 4973216
    [No Abstract]   [Full Text] [Related]  

  • 71. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA
    Scand J Respir Dis Suppl; 1968; 65():147-50. PubMed ID: 4978458
    [No Abstract]   [Full Text] [Related]  

  • 72. [Contagion of drug-resistant Mycobacterium tuberculosis: considerations on the time course of so-called primary resistance].
    Lucchesi M
    Arch Monaldi; 1972; 27(4):436-53. PubMed ID: 4217600
    [No Abstract]   [Full Text] [Related]  

  • 73. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 74. [Therapeutic difficulties encountered in cases of lung tuberculosis treated with drugs].
    Wilczyński J; Paździor E
    Pneumonol Pol; 1977 Feb; 45(2):141-4. PubMed ID: 840726
    [No Abstract]   [Full Text] [Related]  

  • 75. [Anatomoclinical study of the incidence of some factors of chronicization of treated pulmonary tuberculosis].
    Diaconiţă G; Ionescu J; Luţescu L
    Ftiziologia; 1973; 22(5):485-92. PubMed ID: 4751364
    [No Abstract]   [Full Text] [Related]  

  • 76. The chemotherapy of tuberculosis in Bulgaria today.
    Nitchev V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):156-8. PubMed ID: 2999953
    [No Abstract]   [Full Text] [Related]  

  • 77. [Therapy of urogenital tuberculosis].
    Schaberg T; Lode H
    Dtsch Med Wochenschr; 1992 Sep; 117(37):1418-9. PubMed ID: 1516541
    [No Abstract]   [Full Text] [Related]  

  • 78. [Disseminated tuberculosis cutis colliquativa caused by hematogenous dissemination of Mycobacterium tuberculosis].
    Behrendt H; Korting HC; Ring J
    Z Hautkr; 1990 Nov; 65(11):1036-8. PubMed ID: 2080654
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Capreomycin in the treatment of pulmonary tuberculosis.
    Donomae I
    Ann N Y Acad Sci; 1966 Apr; 135(2):1011-38. PubMed ID: 4957083
    [No Abstract]   [Full Text] [Related]  

  • 80. [Chemotherapy of urogenital system tuberculosis].
    Mochalova TP; Danilova NK
    Probl Tuberk; 1976 Jun; (6):83-90. PubMed ID: 1034302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.